Ozempic Could Prevent Diabetes. Should We Use It For That?
Briefly

The new study published in The New England Journal of Medicine demonstrated that the compound in Mounjaro and Zepbound decreased the risk of diabetes by 94% in overweight adults with pre-diabetes.
Most patients on these medications managed to maintain their blood sugar levels within normal ranges after a three-year period, indicating a significant potential for these drugs in preventing diabetes.
However, some healthcare professionals caution against using these drugs as first-line treatments, emphasizing that diet and exercise might often yield effective results for managing pre-diabetes.
Dr. Kristina Henderson Lewis pointed out that while these medications are potent, lifestyle changes or less expensive alternatives might suffice for many individuals, raising concerns about necessity and accessibility.
Read at www.nytimes.com
[
|
]